Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; none of the 48 sources its claims cite is checked for support yet.
Abstract
Background: Plasmodium vivax occurs as a latent infection of liver and a patent infection of red blood cells. Radical cure requires both blood schizontocidal and hypnozoitocidal chemotherapies. The hypnozoitocidal therapies available are primaquine and tafenoquine, 8-aminoquinoline drugs that can provoke threatening acute hemolytic anemia in patients having an X-linked G6PD-deficiency. Heterozygous females may screen as G6PD-normal prior to radical cure and go on to experience hemolytic crisis. Methods & findings: This study examined G6PD phenotypes in 1928 female subjects living in malarious Sumba Island in eastern Indonesia to ascertain the prevalence of females vulnerable to diagnostic misclassification as G6PD-normal. All 367 (19%) females having <80% G6PD normal activity were genotyped. Among those, 103 (28%) were G6PD wild type, 251 (68·4%) were heterozygous, three (0·8%) were compound heterozygotes, and ten (2·7%) were homozygous deficient. The variants Vanua Lava, Viangchan, Coimbra, Chatham, and Kaiping occurred among them. Below the 70% of normal G6PD activity threshold, just 18 (8%) were G6PD-normal and 214 (92%) were G6PD-deficient. Among the 31 females with <30% G6PD normal activity were all ten homozygotes, all three compound heterozygotes, and just 18 were heterozygotes (7% of those). Conclusions: In this population, most G6PD heterozygosity in females occurred between 30% and 70% of normal (69·3%; 183/264). The prevalence of females at risk of G6PD misclassification as normal by qualitative screening was 9·5% (183/1928). Qualitative G6PD screening prior to 8-aminoquinoline therapies against P. vivax may leave one in ten females at risk of hemolytic crisis, which may be remedied by point-of-care quantitative tests.
Overview
CoChat Summary
TL;DR
In 1,928 non-anemic females on Sumba Island, Indonesia, most G6PD deficiency was heterozygous and fell between 30% and 70% of normal activity, a range poorly detected by qualitative CareStart screening. Qualitative G6PD screening before 8-aminoquinoline radical cure may leave about one in ten females (9.5%) at risk of being misclassified as normal and thus vulnerable to hemolytic crisis.
Key findings
- Of 367 females with <80% normal G6PD activity who were genotyped, 103 (28%) were G6PD wild type, 251 (68.4%) were heterozygous, 3 (0.8%) were compound heterozygotes, and 10 (2.7%) were homozygous deficient; variants included Vanua Lava, Viangchan, Coimbra, Chatham, and Kaiping.
- Below the 70% activity threshold, 214/232 (92%) were genotype-confirmed G6PD-deficient and 18 (8%) were G6PD-normal; among 31 females with <30% activity were all 10 homozygotes, all 3 compound heterozygotes, and 18 heterozygotes (7% of heterozygotes).
- Among 251 heterozygotes, 183 (73%) occurred between 30% and 70% of normal activity; the prevalence of females at risk of G6PD misclassification as normal by qualitative screening was 9.5% (183/1928).
- The CareStart qualitative test detected only 33 of 183 (18.0%) heterozygotes with 30–70% activity as G6PD-deficient; at the 70% threshold, sensitivity was 25.1% (95% CI 19.7–31.2), specificity 96.8% (95% CI 95.8–97.6), positive predictive value 21.4% (95% CI 16.2–27.7), and negative predictive value 97.4% (95% CI 97.2–97.5).
Methods
- Cross-sectional prevalence survey conducted in April 2015 in Southwest Sumba, eastern Indonesia (villages Wainyapu, Waiha, and Umbu Ngedo); healthy females ≥6 years old with informed consent were included, and 1,928 of 2,056 screened females had hemoglobin ≥10 g/dL and were analyzed.
- G6PD qualitative testing used the CareStart rapid diagnostic test at point of care; quantitative G6PD activity was measured with the Trinity Biotech spectrophotometric assay as the reference; genotyping was restricted to samples with <80% normal activity using PCR-RFLP for common variants and whole-gene/next-generation sequencing for undigested samples.
- Analyses were performed in R; 100% activity was defined as the mean among samples ≥5 U/g Hb, with diagnostic thresholds set at 10%, 30%, 70%, and 80%; the study assessed CareStart performance against quantitative testing and genotype, using Fisher’s exact test for G6PD prevalence.
Limitations
- The paper states that the study did not compare the Kcat of G6PD from genotypically G6PD-normal and heterozygous females with G6PD activities below 80%, which could help fine-tune hemolytic risk in heterozygous females under oxidative stress.
- The paper states that the actual safety threshold of G6PD activity for primaquine or tafenoquine has not been determined in practice or clinical research on heterozygotes, and that the findings do not offer assurance of safety at a 70% activity threshold.
- Evident from the text: the design was cross-sectional without clinical hemolysis outcomes; genotyping was limited to samples below 80% activity, and some samples negative for the analyzed SNPs were not whole-gene sequenced (ND, presumed G6PD-normal); quantitative G6PD readings were done once per sample.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 28 Not checked · 63 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| TOTAL | 135 | 6 (4.4%) | 201 | 33 (16.4%) | 31 | 25 (80.6%) |”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Diagnostic result of CareStart G6PD rapid test
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| Compound Heterozygous | 0 | 0 | 0 | 0 | 3 | 3 (100%) |”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Diagnostic result of CareStart G6PD rapid test
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Heterozygotes overwhelmingly dominated the 30% to 70% range.”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Laboratory findings
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The CSG detected only 33 of 183 (18·0%) heterozygotes between 30% and 70% of normal G6PD activity as G6PD-deficient.”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Diagnostic result of CareStart G6PD rapid test
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All of the five variants identified at Sumba (Vanua Lava, Viangchan, Chatham, Coimbra, and Kaiping) were Class II and perhaps more vulnerable to 8-aminoquinoline toxicity than Mahidol Class III variant.”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
39 more claims
Create a free account to see all 91 claims and to verify the 47 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 29
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Diagnostic result of CareStart G6PD rapid test
“The overall sensitivity, specificity, positive predictive value, and negative predictive value of the CSG relative to quantitative testing at the 70% of normal activity threshold was 25.1% (95%CI, 19.7–31.2), 96.8% (95%CI, 95.8–97.6), 21.4% (95%CI, 16.2–27.7), and 97.4% (95%CI, 97.2–97.5), respectively.”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Diagnostic result of CareStart G6PD rapid test
“The CSG detected only 33 of 183 (18·0%) heterozygotes between 30% and 70% of normal G6PD activity as G6PD-deficient.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Methods > Study population
“n=(1.96²×0.19×(1‐0.19))/0.02²=1478”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Methods > Study population
“This value was 1345, and we increased that by 30% as a means of ensuring and adequate number heterozygous females for our research purposes, yielding a target sample size of 1921.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“The point-of-care G6PD rapid test identified 1814 women as normal and 113 women as deficient (1 sample did not have CSG data), indicating a prevalence of 6·2% for G6PD deficiency using that device.”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Field survey
Reported 6.2 · recomputed 5.860996
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“P. vivax was found in 53 females, including 11 of 12 mixed species infections (prevalence of 2·6%).”
§ Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria > Results > Field survey
Reported 2.6 · recomputed 2.748963
Citations
Cites
Howes, R. E., Piel, F. B., Patil, A. P., Nyangiri, O. A., Gething, P. W., Dewi, M., Hogg, M. M., Battle, K. E., Padilla, C. D., Baird, J. K., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001339 · Cited by 562
Self-citationBattle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31096-7 · Cited by 409
Self-citationGlucose-6-Phosphate Dehydrogenase Deficiency
Luzzatto, L., Nannelli, C., & Notaro, R. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.006 · Cited by 400
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398 · cited 1×
“Introduction Acute malaria caused by Plasmodium vivax asexual blood stage parasites provokes a debilitating febrile illness that may progress to severe and life-threatening disease syndromes associated with death [1,2].”
BackgroundSelf-citationPrimaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
Bennett, J. W., Pybus, B. S., Yadava, A., Tosh, D., Sousa, J. C., McCarthy, W. F., Deye, G., Melendez, V., & Ockenhouse, C. F. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1301936 · Cited by 293
Geographical variation in Plasmodium vivax relapse
Battle, K. E., Karhunen, M. S., Bhatt, S., Gething, P. W., Howes, R. E., Golding, N., Van Boeckel, T. P., Messina, J. P., Shanks, G. D., Smith, D. L., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-144 · Cited by 282
Self-citationRobinson, L. J., Wampfler, R., Betuela, I., Karl, S., White, M. T., Li Wai Suen, C. S. N., Hofmann, N. E., Kinboro, B., Waltmann, A., Brewster, J., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001891 · Cited by 276
Primaquine: the risks and the benefits
Ashley, E. A., Recht, J., & White, N. J. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-418 · Cited by 252
A simple method for DNA purification from peripheral blood
Ciulla, T. A., Sklar, R. M., & Hauser, S. L. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90047-4 · Cited by 230
Anstey, N. M., Douglas, N. M., Poespoprodjo, J. R., & Price, R. N. (2012) · Advances in Parasitology · doi:10.1016/b978-0-12-397900-1.00003-7 · Cited by 218
Research works printed but not linked: 3
- World Health Organization, 2015, Control and elimination of Plasmodium vivax malaria: a technical brief
- B Ley, 2019, Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis., PLoS Med [Internet].
- S Dini, The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study., BMC Med
Cited by
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
Zhou, Y., & Lauschke, V. M. (2021) · Human Genetics · doi:10.1007/s00439-021-02385-x · Cited by 98
The ethnogeographic variability of genetic factors underlying G6PD deficiency
Koromina, M., Pandi, M., van der Spek, P. J., Patrinos, G. P., & Lauschke, V. M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105904 · Cited by 46
Pfeffer, D. A., Satyagraha, A. W., Sadhewa, A., Alam, M. S., Bancone, G., Boum, Y., Brito, M. A. M., Cui, L., Deng, Z., Domingo, G. J., et al. (2022) · Pathogens · doi:10.3390/pathogens11091045 · Cited by 42
Self-citationSadhewa, A., Cassidy-Seyoum, S. A., Acharya, S., Devine, A., Price, R. N., Mwaura, M., Thriemer, K., & Ley, B. (2023) · Pathogens · doi:10.3390/pathogens12050650 · Cited by 39
Self-citation
Metadata
- Authors
- Satyagraha, A. W., Sadhewa, A., Panggalo, L. V., Subekti, D., Elyazar, I., Soebianto, S., Mahpud, N., Harahap, A. R., & Baird, J. K.
- Affiliations
- Eijkman Institute for Molecular Biology (ID)
- Corresponding author
- Satyagraha, Ari Winasti
- ORCID
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-07-16
- Volume
- 15
- Issue
- 7
- Pages
- e0009610
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- PMC
- PMC8318249
- OpenAlex
- W3180860798
- Semantic Scholar
- 11f30761893f569f4cf16b49a46bac1b61ea3017
- Cited by
- 12
- References
- 45
- Citations by year
- 2026: 3 · 2025: 1 · 2023: 3 · 2022: 2 · 2021: 3
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-07-28)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS neglected tropical diseases (publishedVersion, cc-by)
- Oxford University Research Archive (ORA) (University of Oxford) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- li ka shing global health programme (LG38)
- The Wellcome Trust Asia Africa Programme
- ministry of research, technology and higher education of the republic of indonesia
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- glucose-6-phosphate dehydrogenase deficiency, primaquine, Plasmodium vivax, radical cure, 8-aminoquinolines, hemolytic anemia, diagnostic misclassification, heterozygous females, Sumba Island
- MeSH terms
- Latent Infection, Adolescent, Adult, Aged, Aged, 80 and over, Antimalarials, Child, Female, Glucosephosphate Dehydrogenase, Humans, Indonesia, Plasmodium vivax, Primaquine, Gene Expression Regulation, Enzymologic, Malaria, Vivax, Genetic Predisposition to Disease, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria. https://app.cochat.ai/papers/10.1371/journal.pntd.0009610
- The paper
- Satyagraha, A. W., Sadhewa, A., Panggalo, L. V., Subekti, D., Elyazar, I., Soebianto, S., Mahpud, N., Harahap, A. R., & Baird, J. K. (2021). Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0009610
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.